The 2016 revision of the World Health Organization classification of lymphoid neoplasms. - Wikidata - wikimedia - TriplyDB

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

http://www.wikidata.org/entity/Q36920426

about

Hereditary Predispositions to Myelodysplastic Syndrome The role of HGF/c-MET signaling pathway in lymphoma The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in The New Drugs Era Systemic Front Line Therapy of Follicular Lymphoma: When, to Whom and How Towards Stratified Medicine in Plasma Cell Myeloma Evolution of frontline treatment of diffuse large B-cell lymphoma: a brief review and recent update Diffuse Large B-cell Lymphoma in the elderly: standard treatment and new perspectives.How we treat chronic active Epstein-Barr virus infection.Infection in Organ Transplantation.Burkitt lymphoma in adolescents and young adults: management challenges.Enteropathy-Associated T-Cell Lymphoma.T-cell Lymphoma Epidemiology: the Known and Unknown.Mature aggressive B-cell lymphoma across age groups - molecular advances and therapeutic implications.Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.Multicenter Comparison of Contrast-Enhanced FDG PET/CT and 64-Slice Multi-Detector-Row CT for Initial Staging and Response Evaluation at the End of Treatment in Patients With Lymphoma Cost-effective approach to the diagnostic workup of B cell lymphoproliferative disorders via optimal integration of flow cytometric data.Clinical and Radiologic Responses to Cladribine for the Treatment of Erdheim-Chester Disease.The heterogeneous landscape of ALK negative ALCL.Characterization and risk estimate of cancer in patients with primary Sjögren syndrome Multiple myeloma: routes to diagnosis, clinical characteristics and survival - findings from a UK population-based study.EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in ASXL1, BCOR, CDKN2A, NF1, and TP53 Role of MYC in B Cell Lymphomagenesis.Understanding rare adverse sequelae of breast implants: anaplastic large-cell lymphoma, late seromas, and double capsules.CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.ALK-positive anaplastic large cell lymphoma undiagnosed in a patient with tuberculosis: a case report and review of the literature Toward a Biology-Driven Treatment Strategy for Peripheral T-cell Lymphoma Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.Retinoic acid receptor alpha drives cell cycle progression and is associated with increased sensitivity to retinoids in T-cell lymphoma.Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature.Molecular Testing of Lymphoproliferative Disorders: Current Status and Perspectives.Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network Comparison of pediatric and adult lymphomas involving the mediastinum characterized by distinctive clinicopathological and radiological features.Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome)The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions.Gamma-delta (γδ) T-cell lymphoma - another case unclassifiable by World Health Organization classification: a case report.Clinical analysis of 42 cases of EBV-positive mature T/NK-cell neoplasms.Epstein-Barr Virus-Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification.NCCN Consensus Guidelines for the Diagnosis and Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma.Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing.

P2860

Q26744199-748A67BE-9CCA-4DAE-8F43-4BF9A9ADCBC1 Q28069836-2024A891-EF9C-4157-A003-5FCE5FDAF93F Q28072397-5FEC8131-57F0-4F4D-82E6-2552AFACC2FE Q28073262-CF0B174B-D502-437C-B582-AC91290B0E92 Q28074994-44C0AE24-4486-486B-B7C1-DCCA894C5383 Q28078869-4C193755-9F1F-4DC4-8A4F-312DD3827D8C Q30235296-A42A7FBC-FE01-4C26-ACC7-545BD71A24E1 Q30235902-56B538E2-9828-4124-8CE8-647F24A2B548 Q30238810-398D5580-C118-4B1D-A0C5-D9C2DC425130 Q30238965-E499AD66-32BB-4EA7-AB38-67E7D994B903 Q30239728-08FEAE20-D06E-4911-949A-51C083E2CA9C Q30239985-2FEBA092-8CE2-4360-93D4-13E0703EAC46 Q30240133-CB5608D7-E667-4D75-94FC-FF833E222E60 Q30244110-EEDD2C47-FE8A-44AB-A08E-81CBB39583DD Q30275206-083B9D34-24AB-46D6-9282-6958BF063F6D Q30491972-CF5F5937-A496-4001-9C7E-8B9DFB274B83 Q31157712-DF15DCC4-831C-4C8A-BFC1-6E603B573052 Q33439784-48BC7FB6-76BB-40A8-BB32-C68208F06FC0 Q33567012-9B9C3344-F4BF-43FB-B214-3837082772E2 Q33568158-D78D59D4-519A-45FC-A894-36A035AB8AA6 Q33578273-B220D91F-ED1C-409A-AC10-B26DDFD9557A Q33594139-E5B10860-8BDA-42A3-8D5D-B1DFD7C42AC6 Q33608499-9C1CCABE-4DDE-47E2-BE36-E75B83F7CDB6 Q33617362-172D9C8A-4E57-4C85-AB61-8E2B8762CA1E Q33655362-76F4CDFB-7D3F-454B-B3D0-0D76D31991C7 Q33660393-DA0924F0-41D6-44A6-A385-3BEECF65099E Q33670421-3D4763DB-C5A3-46C5-AE57-1F88757721AA Q33670880-41C35772-3676-403D-B83B-147B31744023 Q33688613-608F53E1-1468-4852-AD21-49F537CF0AD7 Q33701364-EEEF5413-A928-4C48-8C2D-DBCA36D61271 Q33729711-4C5CCF79-8DAD-437C-95DF-D0EF5A6AE012 Q33732402-29364CB7-836F-43A3-9BF0-73DE7367CEAA Q33747063-AE63021C-069C-46F8-B0CD-8A8C26CB17B2 Q33781845-BFA14863-7ECF-4B44-880F-40FE1C618127 Q33798887-77B421A7-0BAA-4DE0-A603-2507A98F0B3C Q33810490-9A6BFB7E-BC12-4D4E-9199-D921D762EEF4 Q33846399-730F9E19-23A8-4DEC-9529-3062213770A5 Q33925581-10FA5F64-536B-44EC-A729-B45E6DB41BBB Q34550971-4AD5619F-CAC6-42FC-B297-31659BBA169F Q36210487-A8238CA4-7020-48DD-AD88-482752865312

P2860

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

http://www.wikidata.org/entity/Q36920426

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

@en

type

label

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

@en

prefLabel

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

@en

P1433

Q36920426-F3042464-D4E2-4222-B5A9-AB0C84E890CA

P1476

Q36920426-3197540B-7D88-4627-93F2-287E00ED7B4E

P2093

Q36920426-397FAB1D-7B8F-453B-8BA2-3A5F2B100B15

Q36920426-53FE9B3A-B9CC-45E8-B5ED-872F5F9541EC

Q36920426-5EEDABFE-E08A-44E6-BA6A-4EC57A9A424F

Q36920426-8DD4BD20-453E-4411-BC8B-2E58B92659E0

Q36920426-8E39DB20-8C18-4FC5-A7DB-E3D3A3585BD1

Q36920426-A4489F3D-C571-45F9-A7E6-977B6B840226

Q36920426-C4AF6EC9-2973-4B17-9D56-1FA98C0A69C9

P2860

Q36920426-008C872D-4A84-4D5F-8465-05937AB4CEF2

Q36920426-01FBE89F-A06D-47D1-9583-F6E8645F0C7F

Q36920426-032725E3-3D70-4EA8-BB03-4B743C7AA007

Q36920426-03A1DCA3-9BCE-4ED9-A87C-D382D4448409

Q36920426-054C4778-7045-4BA2-B813-521910D17460

Q36920426-07074973-6F09-40C8-93F8-099B0A8E6A54

Q36920426-081B1FB2-B032-42FE-9BAF-D2DBD520F416

Q36920426-089E0E24-2EE0-462F-8156-C5A0CA496B6D

Q36920426-0A13F69C-7ED2-4389-8D51-5D5AE13A7EB2

Q36920426-0E0967F9-D5AC-4D0E-8645-7C4C01A688A3

P304

Q36920426-B003A98E-C93E-4CE2-93C7-0BE1F1D0515B

P31

Q36920426-36E15F63-009C-47A8-975B-BAA97A832F3A

P356

Q36920426-9FF74444-5A4E-4C7F-B1B0-B7B8B9808794

P407

Q36920426-91772850-6EBD-451E-8112-14BE376E7EC7

P433

Q36920426-4420DCE3-CCC3-492D-9A6F-AA4EA77B8E57

P478

Q36920426-DBEEBD88-507F-43AD-ADB6-746F86D82224

P50

Q36920426-1968865A-2B79-4611-AEFC-6C8B77AD7566

Q36920426-599A0012-90D3-4696-9D41-E60F3DC73CB5

Q36920426-B7A21AA2-2C2F-4204-9DCB-B27E0F739A3C

Q36920426-B7AA0DB4-94D4-421B-BBE4-EE919044890A

P577

Q36920426-3182B097-A699-46B4-9F9B-548E1A24F897

P698

Q36920426-44E35134-7940-4475-AE49-85584EBB2F79

P921

Q36920426-FCE419AB-A23F-4C51-9D75-D878196185EE

P932

Q36920426-2F161819-A6F3-4D2E-8550-A80B81E76DD0

P356

BLOOD-2016-01-643569

P1433

P1476

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

@en

P2093

Andrew D Zelenetz

http://www.w3.org/2001/XMLSchema#string

Harald Stein

http://www.w3.org/2001/XMLSchema#string

Michele Ghielmini

http://www.w3.org/2001/XMLSchema#string

Nancy Lee Harris

http://www.w3.org/2001/XMLSchema#string

Ranjana Advani

http://www.w3.org/2001/XMLSchema#string

Reiner Siebert

http://www.w3.org/2001/XMLSchema#string

Stefano A Pileri

http://www.w3.org/2001/XMLSchema#string

P2860

BRAF mutations in hairy-cell leukemia

The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing

The genetic landscape of diffuse large B-cell lymphoma

Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.

Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.

IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.

Somatic STAT3 mutations in large granular lymphocytic leukemia

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.

P304

2375-2390

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2016-01-643569

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P50

Gilles A Salles

Steven H Swerdlow

P577

2016-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26980727

http://www.w3.org/2001/XMLSchema#string

P921

Alþjóðaheilbrigðismálastofnunin

P932

4874220

http://www.w3.org/2001/XMLSchema#string